Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Pinwheel-Shaped Titanium Plates Should Be Fixed to the Skull Using All Screw Holes to Protect the Plates from Being Bent.

Yamada SM, Gorai K, Gonda K.

Case Rep Surg. 2019 Aug 19;2019:5709285. doi: 10.1155/2019/5709285. eCollection 2019.

2.

Flap Blood Glucose as a Sensitive and Specific Indicator for Flap Venous Congestion: A Rodent Model Study.

Mochizuki K, Mochizuki M, Gonda K.

Plast Reconstr Surg. 2019 Sep;144(3):409e-418e. doi: 10.1097/PRS.0000000000005957.

PMID:
31461018
3.

Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer.

Shimura T, Shibata M, Gonda K, Murakami Y, Noda M, Tachibana K, Abe N, Ohtake T.

Oncol Lett. 2019 Jun;17(6):5139-5146. doi: 10.3892/ol.2019.10183. Epub 2019 Mar 21.

4.

MLH1 germline mutation associated with Lynch syndrome in a family followed for more than 45 years.

Momma T, Gonda K, Akama Y, Endo E, Ujiie D, Fujita S, Maejima Y, Horita S, Shimomura K, Saji S, Kono K, Yashima R, Watanabe F, Sugano K, Nomizu T.

BMC Med Genet. 2019 May 2;20(1):67. doi: 10.1186/s12881-019-0792-0.

5.

Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2- Breast Cancer.

Guo Z, Tada H, Kitamura N, Hamada Y, Miyashita M, Harada-Shoji N, Sato A, Hamanaka Y, Tsuboi K, Harada N, Takano-Kasuya M, Okada H, Nakano Y, Ohuchi N, Hayashi SI, Ishida T, Gonda K.

Cancers (Basel). 2019 Apr 12;11(4). pii: E526. doi: 10.3390/cancers11040526.

6.

[Laparoscopic Endoscopic Cooperative Surgery(LECS)for Duodenal Tumors].

Ohki S, Hikichi T, Momma T, Watanabe K, Nakamura J, Yamada R, Ujiie D, Nirei A, Tada T, Hanayama H, Watanabe Y, Hayase S, Gonda K, Saze Z, Kono K.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2024-2026. Japanese.

PMID:
30692432
7.

[A Case of Esophageal Cancer with Cervical Lymph Node Recurrence Six Years after Complete Response to Definitive Chemoradiotherapy].

Fujita S, Ohki S, Hayase S, Ujiie D, Kikuchi T, Tada T, Hanayama H, Okayama H, Sakamoto W, Endo H, Saito M, Gonda K, Saze Z, Momma T, Kono K.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1821-1823. Japanese.

PMID:
30692365
8.

Reply: Evaluation of In Vivo Kinetics and Biostimulatory Effects of Subcutaneously Injected Hyaluronic Acid Filler.

Aoi N, Mochizuki M, Gonda K, Hirabayashi S, Komuro Y.

Plast Reconstr Surg. 2019 Mar;143(3):659e-660e. doi: 10.1097/PRS.0000000000005333. No abstract available.

PMID:
30601305
9.

Quantitative analyses of amount and localization of radiosensitizer gold nanoparticles interacting with cancer cells to optimize radiation therapy.

Hatoyama K, Kitamura N, Takano-Kasuya M, Tokunaga M, Oikawa T, Ohta M, Hamada Y, Tada H, Kobayashi Y, Kamei T, Gonda K.

Biochem Biophys Res Commun. 2019 Jan 22;508(4):1093-1100. doi: 10.1016/j.bbrc.2018.12.016. Epub 2018 Dec 12.

PMID:
30551875
10.

[A Case of Recurrent Colon Cancer with Peritoneal Dissemination Treated with Aflibercept Showing Partial Response for One Year].

Gonda K, Fujita S, Shibata M, Hatakeyama Y, Tachiya Y, Rokkaku Y, Saze Z, Momma T, Ohki S, Saji S, Kono K.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1539-1542. Japanese.

PMID:
30382071
11.

[A Case of Rectal Colon Cancer with Paraneoplastic Cerebellar Degeneration].

Gonda K, Kikuchi T, Shibata M, Hatakeyama Y, Tachiya Y, Rokkaku Y, Endo H, Fujita S, Sakamoto W, Hayase S, Okayama H, Hanayama H, Tada T, Nirei A, Ujiie D, Yamada R, Saze Z, Momma T, Ohki S, Kono K.

Gan To Kagaku Ryoho. 2018 Oct;45(10):1510-1512. Japanese.

PMID:
30382061
12.

Poland syndrome accompanied by internal iliac artery supply disruption sequence: a case report.

Gonda K, Tachiya Y, Hatakeyama Y, Momma T, Tamaoki T, Maejima Y, Rokkaku Y, Saji S, Shimomura K, Kono K.

J Med Case Rep. 2018 Oct 26;12(1):312. doi: 10.1186/s13256-018-1823-8.

13.

Prognostic impact of soluble intercellular adhesion molecule-1 in hepatocellular carcinoma.

Shimura T, Shibata M, Gonda K, Kofunato Y, Ishigame T, Okada R, Sato N, Kimura T, Kenjo A, Marubashi S.

Oncol Lett. 2018 Nov;16(5):6013-6018. doi: 10.3892/ol.2018.9367. Epub 2018 Aug 24.

14.

Prognostic impact of elevated preoperative C-reactive protein on patients with differentiated thyroid carcinoma.

Shimura T, Shibata M, Gonda K, Matsumoto Y, Nakano K, Iwadate M, Suzuki S, Suzuki S.

J Surg Res. 2018 Nov;231:338-345. doi: 10.1016/j.jss.2018.05.070. Epub 2018 Jun 28.

PMID:
30278950
15.

Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.

Shimura T, Shibata M, Gonda K, Hayase S, Sakamoto W, Okayama H, Fujita S, Saito M, Momma T, Ohki S, Kono K.

Fukushima J Med Sci. 2018 Aug 29;64(2):64-72. doi: 10.5387/fms.2018-10. Epub 2018 Jul 14.

16.

Evaluation of the In Vivo Kinetics and Biostimulatory Effects of Subcutaneously Injected Hyaluronic Acid Filler.

Mochizuki M, Aoi N, Gonda K, Hirabayashi S, Komuro Y.

Plast Reconstr Surg. 2018 Jul;142(1):112-121. doi: 10.1097/PRS.0000000000004496.

PMID:
29952893
17.

Impact of prestorage leucoreduction of autologous whole blood on length of hospital stay with a subgroup analysis in bilateral hip arthroplasty.

Sawamura Y, Ohto H, Ikeda K, Kanno T, Suzuki Y, Gonda K, Tasaki T, Nollet KE, Takahashi H, Aota S.

Vox Sang. 2018 Jun 20. doi: 10.1111/vox.12674. [Epub ahead of print]

PMID:
29923207
18.

Serum transthyretin level is associated with prognosis of patients with gastric cancer.

Shimura T, Shibata M, Gonda K, Okayama H, Saito M, Momma T, Ohki S, Kono K.

J Surg Res. 2018 Jul;227:145-150. doi: 10.1016/j.jss.2018.02.035. Epub 2018 Mar 15.

PMID:
29804846
19.

Eccrine porocarcinoma arising from the knee.

Gonda K, Hatakeyama Y, Rokkaku Y.

Clin Case Rep. 2018 Jan 4;6(2):350-352. doi: 10.1002/ccr3.1319. eCollection 2018 Feb.

20.

Elevated neutrophil-to-lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S-1 plus cisplatin, and poor prognosis in patients with stage IV gastric cancer.

Gonda K, Shibata M, Sato Y, Washio M, Takeshita H, Shigeta H, Ogura M, Oka S, Sakuramoto S.

Mol Clin Oncol. 2017 Dec;7(6):1073-1078. doi: 10.3892/mco.2017.1438. Epub 2017 Oct 4.

21.

Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy.

Wang P, Zhang L, Zheng W, Cong L, Guo Z, Xie Y, Wang L, Tang R, Feng Q, Hamada Y, Gonda K, Hu Z, Wu X, Jiang X.

Angew Chem Int Ed Engl. 2018 Feb 5;57(6):1491-1496. doi: 10.1002/anie.201708689. Epub 2018 Jan 15.

PMID:
29282854
22.

Global Structural Flexibility of Metalloproteins Regulates Reactivity of Transition Metal Ion in the Protein Core: An Experimental Study Using Thiol-subtilisin as a Model Protein.

Matsuo T, Kono T, Shobu I, Ishida M, Gonda K, Hirota S.

Chemistry. 2018 Feb 21;24(11):2767-2775. doi: 10.1002/chem.201705920. Epub 2018 Feb 6.

PMID:
29282778
23.

Insights from clinical experience in treating IVF poor responders.

Gonda KJ, Domar AD, Gleicher N, Marrs RP.

Reprod Biomed Online. 2018 Jan;36(1):12-19. doi: 10.1016/j.rbmo.2017.09.016. Epub 2017 Oct 24. Review.

PMID:
29223475
24.

[Three Cases of High-Grade Malignant Cancer of Unknown Primary with a Long-Term Survival].

Gonda K, Shibata M, Yasuda M, Tachiya Y, Hatakeyama Y, Kono K, Rokkaku Y.

Gan To Kagaku Ryoho. 2017 Oct;44(10):950-952. Japanese.

PMID:
29066706
25.

[Two Cases of Unresectable Advanced Rectal Cancer with a Long-Term Survival for Which Pathological Complete Response Was Achieved through Neoadjuvant Effective Chemotherapy].

Gonda K, Tachiya Y, Hatakeyama Y, Shibata M, Kono K, Rokkaku Y.

Gan To Kagaku Ryoho. 2017 Oct;44(10):944-946. Japanese.

PMID:
29066704
26.

Clinical Significance of Soluble Intercellular Adhesion Molecule-1 and Interleukin-6 in Patients with Extrahepatic Cholangiocarcinoma.

Shimura T, Shibata M, Gonda K, Kofunato Y, Okada R, Ishigame T, Kimura T, Kenjo A, Marubashi S, Kono K, Takenoshita S.

J Invest Surg. 2018 Dec;31(6):475-482. doi: 10.1080/08941939.2017.1358310. Epub 2017 Sep 19.

PMID:
28925763
27.

Significance of Circulating Galectin-3 in Patients with Pancreatobiliary Cancer.

Shimura T, Shibata M, Gonda K, Kofunato Y, Okada R, Ishigame T, Kimura T, Kenjo A, Kono K, Marubashi S.

Anticancer Res. 2017 Sep;37(9):4979-4986.

PMID:
28870921
28.

Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness.

Gonda K, Watanabe M, Tada H, Miyashita M, Takahashi-Aoyama Y, Kamei T, Ishida T, Usami S, Hirakawa H, Kakugawa Y, Hamanaka Y, Yoshida R, Furuta A, Okada H, Goda H, Negishi H, Takanashi K, Takahashi M, Ozaki Y, Yoshihara Y, Nakano Y, Ohuchi N.

Sci Rep. 2017 Aug 8;7(1):7509. doi: 10.1038/s41598-017-06534-z.

29.

Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer.

Gonda K, Shibata M, Ohtake T, Matsumoto Y, Tachibana K, Abe N, Ohto H, Sakurai K, Takenoshita S.

Oncol Lett. 2017 Aug;14(2):1766-1774. doi: 10.3892/ol.2017.6305. Epub 2017 Jun 2.

30.

Increased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinoma.

Sato Y, Gonda K, Harada M, Tanisaka Y, Arai S, Mashimo Y, Iwano H, Sato H, Ryozawa S, Takahashi T, Sakuramoto S, Shibata M.

Biomed Rep. 2017 Jul;7(1):79-84. doi: 10.3892/br.2017.924. Epub 2017 Jun 7.

31.

A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.

Shidahara M, Thomas BA, Okamura N, Ibaraki M, Matsubara K, Oyama S, Ishikawa Y, Watanuki S, Iwata R, Furumoto S, Tashiro M, Yanai K, Gonda K, Watabe H.

Ann Nucl Med. 2017 Aug;31(7):563-569. doi: 10.1007/s12149-017-1185-0. Epub 2017 Jun 21.

PMID:
28639126
32.

PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.

Kogashiwa Y, Yasuda M, Sakurai H, Nakahira M, Sano Y, Gonda K, Ikeda T, Inoue H, Kuba K, Oba S, Ishikawa J, Enoki Y, Matsumura S, Minami K, Ebihara Y, Sugasawa M.

Anticancer Res. 2017 Mar;37(3):1417-1424.

PMID:
28314313
33.

[Axillary Lymph Node Dissection and Chemotherapy were Useful for Occult Cancer - Report of a Case].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Hirano T, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2065-2067. Japanese.

PMID:
28133223
34.

[Difficult Decision about a Surgical Margin for a Non-Invasive Apocrine Carcinoma in the Breast - Report of a Case].

Hirano T, Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2013-2015. Japanese.

PMID:
28133206
35.

[Breast Cancer with Microinvasion and Lymph Node Metastasis Diagnosed by Microdochectomy - Report of a Case].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Hirano T, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1455-1457. Japanese.

PMID:
28133021
36.

Fabrication of silica-coated gold nanorods and investigation of their property of photothermal conversion.

Inose T, Oikawa T, Shibuya K, Tokunaga M, Hatoyama K, Nakashima K, Kamei T, Gonda K, Kobayashi Y.

Biochem Biophys Res Commun. 2017 Mar 4;484(2):318-322. doi: 10.1016/j.bbrc.2017.01.112. Epub 2017 Jan 23.

PMID:
28126339
37.

Prediction of the Clinical SUV Ratio in Amyloid PET Imaging Using a Biomathematic Modeling Approach Toward the Efficient Development of a Radioligand.

Arakawa Y, Nai Y, Shidahara M, Furumoto S, Seki C, Okamura N, Tashiro M, Kudo Y, Yanai K, Gonda K, Watabe H.

J Nucl Med. 2017 Aug;58(8):1285-1292. doi: 10.2967/jnumed.116.183566. Epub 2017 Jan 6.

38.

X-ray computed tomography imaging of a tumor with high sensitivity using gold nanoparticles conjugated to a cancer-specific antibody via polyethylene glycol chains on their surface.

Nakagawa T, Gonda K, Kamei T, Cong L, Hamada Y, Kitamura N, Tada H, Ishida T, Aimiya T, Furusawa N, Nakano Y, Ohuchi N.

Sci Technol Adv Mater. 2016 Jul 26;17(1):387-397. eCollection 2016.

39.

Quantitative diagnosis of HER2 protein expressing breast cancer by single-particle quantum dot imaging.

Miyashita M, Gonda K, Tada H, Watanabe M, Kitamura N, Kamei T, Sasano H, Ishida T, Ohuchi N.

Cancer Med. 2016 Oct;5(10):2813-2824. doi: 10.1002/cam4.898. Epub 2016 Sep 26.

40.

[Indoleamine 2,3-Dioxygenase Activity in Intracystic Breast Tumors].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Enomoto K, Hirano T, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1295-1297. Japanese.

PMID:
27760965
41.

[Clinical Evaluation of Immunosuppressive Acidic Protein in the Serum of Patients with Locally Advanced Breast Cancer during Mohs Paste Treatment].

Hirano T, Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1283-1285. Japanese.

PMID:
27760961
42.

[Study of the Immunological Stress Caused by Breast Surgery Methods].

Hirano T, Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1274-1276. Japanese.

PMID:
27760958
43.

[Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Multiple Metastatic Breast Cancer Patients].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Hirano T, Enomoto K, Tomita R, Gonda K.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1233-1236. Japanese.

PMID:
27760945
44.

Association between circulating galectin-3 levels and the immunological, inflammatory and nutritional parameters in patients with colorectal cancer.

Shimura T, Shibata M, Gonda K, Nakajima T, Chida S, Noda M, Suzuki S, Nakamura I, Ohki S, Takenoshita S.

Biomed Rep. 2016 Aug;5(2):203-207. Epub 2016 May 30.

45.

Difference in the timing of cessation of palliative chemotherapy between patients with incurable cancer receiving therapy only in a local hospital and those transitioned from a tertiary medical center to a local hospital.

Kamiyama H, Kurosawa K, Ozawa T, Kobayashi K, Gonda K, Teshigawara M, Sato A, Maekawa K, Matoba M.

J Community Support Oncol. 2015 Nov;13(11):405-10. doi: 10.12788/jcso.0180.

PMID:
26863021
46.

[Interval Breast Cancer with Neuroendocrine Differentiation].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Tomita R, Gonda K, Hirano T, Enomoto K, Amano S.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1770-2. Japanese.

PMID:
26805167
47.

[Usefulness of Local Therapy in Elderly Breast Cancer Patients with Distant Metastases].

Sakurai K, Fujisaki S, Suzuki S, Adachi K, Masuo Y, Nagashima S, Hara Y, Enomoto K, Tomita R, Gonda K, Hirano T, Amano S.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1503-5. Japanese.

PMID:
26805077
48.

Performance evaluation of the small-animal PET scanner ClairvivoPET using NEMA NU 4-2008 Standards.

Sato K, Shidahara M, Watabe H, Watanuki S, Ishikawa Y, Arakawa Y, Nai YH, Furumoto S, Tashiro M, Shoji T, Yanai K, Gonda K.

Phys Med Biol. 2016 Jan 21;61(2):696-711. doi: 10.1088/0031-9155/61/2/696. Epub 2015 Dec 30.

PMID:
26716872
49.

[Indoleamine 2,3-Dioxygenase Activity during I131-Radioisotope Therapy for Metastatic Thyroid Cancer].

Sakurai K, Fujisaki S, Adachi K, Suzuki S, Masuo Y, Nagashima S, Hara Y, Tomita R, Gonda K, Hirano T, Enomoto K.

Gan To Kagaku Ryoho. 2015 Oct;42(10):1259-61. Japanese.

PMID:
26489565
50.

[Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Aromatase Inhibitor-Resistant Metastatic Breast Cancer].

Sakurai K, Fujisaki S, Suzuki S, Adachi K, Nagashima S, Masuo Y, Tomita R, Gonda K, Enomoto K, Amano S, Matsuo S, Umeda N.

Gan To Kagaku Ryoho. 2015 Oct;42(10):1225-7. Japanese.

PMID:
26489554

Supplemental Content

Support Center